Eric D. Shaff

CIK 1643734 · CEO and President · last filed 2026-05-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$68.6K

Companies

2

Total Filings

33

Lifetime Open-Market Net

-$913.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MCRB CEO and President 12,040 $5.70 $68.6K -$913.2K 29 2026-05-19
Sigilon Therapeutics, Inc. (SGTX) Delisted Director $22.47 $0 4 2023-08-11

Recent Filings · Page 2 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-17 MCRB Mixed +5,377 -$2.3K EDGAR
2024-02-16 MCRB Mixed +19,701 -$12.5K EDGAR
2023-10-31 MCRB Mixed +19,286 -$11.5K EDGAR
2023-08-11 Sigilon Therapeutics, Inc. (SGTX) Delisted Disp (D) $0 EDGAR
2023-05-22 Sigilon Therapeutics, Inc. (SGTX) Delisted Grant (A) $0 EDGAR
2023-02-07 MCRB Grant (A) $0 EDGAR
2022-07-06 MCRB Grant (A) +63,492 $200.0K EDGAR
2022-05-27 Sigilon Therapeutics, Inc. (SGTX) Delisted Grant (A) $0 EDGAR
2022-02-08 MCRB Grant (A) $0 EDGAR
2021-06-28 Sigilon Therapeutics, Inc. (SGTX) Delisted Grant (A) $0 EDGAR
Showing 1120 of 33
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.